EU countries are in no hurry to waive vaccine patents

Waiving patents may be a solution in the long term but does not generate more vaccines now, say EU countries.

President of the European Council Charles Michel | Photo: POOL/REUTERS / X80003

EU member countries are ready to look into whether the EU should waive covid-19 vaccine patents.

However, this is no urgent matter, as the patents are not what is currently preventing developing countries from getting vaccines more quickly, according to an informal meeting of the members of the European Council in Porto.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs